Future Health Featured Articles

Future Health articles are available to CHR donors. To become a donor or to subscribe to the quarterly see Support/Subscribe.

  • Finding genes for retinal degeneration has immediate benefits for people living with blindness and vision loss, their families, and their physicians. Establishing a genetic cause confirms the clinical diagnosis at the
    molecular level, helps predict the future visual prognosis, suggests therapies, and allows some patients to join clinical trials. While more than 200 genes for retinal...

  • Brain cancer patients may live longer thanks to a new cancer-detection method developed by researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC, and Polytechnique Montréal. The collaborative team has created a powerful new intraoperative probe for detecting cancer cells. The handheld Raman spectroscopy probe enables surgeons, for the...

  • For the first time ever, scientists have access to a high definition view of the molecular events of reprogramming, which is the process of converting adult body cells to stem cells.

    In five Nature and Nature Communications papers, researchers led by Dr. Andras Nagy at the Lunenfeld-Tanenbaum Research Institute (LTRI), Toronto, ON, are the first to map out the major...

  • Marc Bomhof would like to amend the old saying, “You are what you eat”, to be more accurate. Perhaps something like: “You are what you and your gut microbiota eat”.

    “About 100 trillion bacteria live in our digestive tract,” explains Bomhof. “We have about 10 trillion human cells versus 100 trillion bacterial cells and so we’re essentially 10% human and 90% bacteria. These things...

  • According to a study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), medication used to treat bone deterioration in post-menopausal women may slow the spread (metastasis) of breast cancer to the skeleton. This study, published in the Journal of the National Cancer Institute (JNCI), is among the first to link bisphosphonate, a common osteoporosis...

  • The past year marks one of the most difficult in the history of CHR, as the organization has coped with diminished financial resources and the ongoing challenge of reshaping its administration to preserve institutional goals.
    With regard to finances, there were increased costs associated with the upgrading and maintenance of the Web site, as well as legal fees associated with obtaining a...

  • When it comes to heart disease, Dr. Ross Feldman says women are often in the dark.

    When it comes to heart disease, Dr. Ross Feldman says women are often in the dark. Historically, it was thought heart disease was a men’sonly disease; however, data has shown that postmenopausal women are just as likely as men to get heart disease and are less likely to be adequately diagnosed and treated...

  • The 2014 Annual General Meeting of Canadians for Health Research will be held at 11:00 a.m. on Friday, November 14, 2014 at 3647 Peel Street, Montreal, Quebec

  • A study published in Nature Neuroscience by Yves De Koninck and Robert Bonin, two researchers from the Faculty of Medicine at Université Laval and Institut universitaire en santé mentale de Québec (IUSMQ), reveals that it is possible to relieve pain hypersensitivity by using a new method that involves rekindling pain, so that it can subsequently be erased. This discovery could lead to...

Pages